survival times

Experimental Drug Shows Promise In Treating Certain Lymphomas

ScienceDaily  Sun, 04/20/2008 - 18:00

Data showed that AME-133v had a potent tumor-halting response in patients with follicular lymphoma, a portion of lymphoma cases.

Results add to research showing a new class of monoclonal antibodies like AME-133v may lengthen survival times, according to researchers at the University of Alabama at Birmingham.

Tags:

 

Experimental drug shows promise in treating certain lymphomas

EurekAlert! - Chemistry, Physics and Materials Sciences  Tue, 04/15/2008 - 22:00

Data showed that AME-133v had a potent tumor-halting response in patients with follicular lymphoma, a portion of lymphoma cases.

Results add to research showing a new class of monoclonal antibodies like AME-133v may lengthen survival times, according to researchers at the University of Alabama at Birmingham.

Tags: